{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:30:47Z","timestamp":1791923447198,"version":"4.3.4"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>\n                    Cannabis use represents a significant environmental risk factor for psychotic disorders, with emerging evidence suggesting complex interactions between cannabinoid exposure, dissociative experiences, and fundamental disturbances of self-experience (self-disorders) in early psychosis. This systematic review examines the phenomenological and neurobiological relationships among dissociation, cannabis use, and self-disturbance in first-episode psychosis (FEP) patients. Following PRISMA guidelines, we conducted a comprehensive search of four databases (PubMed, Scopus, PsycINFO, Web of Science) from January 1990 to September 2025, identifying 22 studies meeting inclusion criteria (total N = 3,847 participants). Results demonstrate that cannabis use, particularly high-potency THC products, is consistently associated with significantly elevated dissociative experiences compared to non-using FEP patients. Across studies employing the Dissociative Experiences Scale-II (DES-II), cannabis users showed score elevations of 11\u201313 points, exceeding clinically significant thresholds and persisting at follow-up assessments. Daily high-potency cannabis use was associated with three-fold increased odds of clinically significant dissociation (OR: 3.21, 95% CI: 2.14-4.82) and more severe anomalous self-experiences compared to non-using patients. Multiple mechanisms mediate these relationships: alterations in CB1 receptor availability and endocannabinoid system dysregulation in regions critical for self-awareness, disruption of neural networks supporting minimal self-consciousness, and acute psychotomimetic effects including depersonalization and derealization that may persist beyond intoxication periods. Cannabis-related dissociation shows distinct phenomenological characteristics compared to primary dissociative disorders, with greater self-world boundary confusion and more severe distortions of first-person perspective. Longitudinal studies indicate that persistent dissociative symptoms and self-disorders in cannabis-using FEP patients predict poorer functional outcomes (12-month GAF scores: 52 \u00b1 14\n                    <jats:italic>vs<\/jats:italic>\n                    . 67 \u00b1 12 in non-users, p&amp;lt;0.001) and increased symptom chronicity. However, approximately 75% of patients showed dissociation reduction following cannabis cessation, suggesting potential reversibility. GRADE certainty of evidence was rated as moderate for dissociative symptom severity (downgraded for observational study designs) and low for self-disturbance outcomes (limited direct evidence with EASE assessment). This review highlights the importance of comprehensive phenomenological assessment in cannabis-using FEP patients, incorporating dissociative symptomatology and basic self-disturbance evaluation, with implications for early intervention strategies and targeted therapeutic approaches. Future research should employ longitudinal designs with repeated phenomenological assessments, biological verification of cannabis exposure, and integration of neuroimaging with experiential measures to elucidate causal mechanisms.\n                  <\/jats:p>","DOI":"10.3389\/fpsyt.2025.1733254","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:32:00Z","timestamp":1767591120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Self-disturbance in first-episode psychosis: Theoretical framework and potential cannabis interactions - a systematic review"],"prefix":"10.3389","volume":"16","author":[{"given":"Valerio","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"De Berardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Maina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the association between the level of cannabis use and risk of psychosis","volume":"42","author":"Marconi","year":"2016","journal-title":"Schizophr Bull"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41537-022-00286-0","article-title":"Association between formal thought disorder and cannabis use: a systematic review and meta-analysis","volume":"8","author":"Argote","year":"2022","journal-title":"Schizophr (Heidelberg Germany)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/0004867415599846","article-title":"Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use","volume":"50","author":"Myles","year":"2016","journal-title":"Aust New Z J Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbv154","article-title":"Cannabis use is associated with increased psychotic symptoms and poorer psychosocial functioning in first-episode psychosis: A report from the UK national EDEN study","volume":"42","author":"Seddon","year":"2016","journal-title":"Schizophr Bull"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115053","article-title":"First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness","volume":"320","author":"Ricci","year":"2023","journal-title":"Psychiatry Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbaa201","article-title":"The self in the spectrum: A meta-analysis of the evidence linking basic self-disorders and schizophrenia","volume":"47","author":"Raballo","year":"2021","journal-title":"Schizophr Bull"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbaf071","article-title":"Schizophrenia, consciousness, and the self\u201d Twenty years later: revisiting the ipseity-disturbance model and the developmental nature of self-disorder in the schizophrenia spectrum","volume":"51","author":"Raballo","year":"2025","journal-title":"Schizophr Bull"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a007017","article-title":"Schizophrenia, consciousness, and the self","volume":"29","author":"Sass","year":"2003","journal-title":"Schizophr Bull"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000088441","article-title":"EASE: examination of anomalous self-experience","volume":"38","author":"Parnas","year":"2005","journal-title":"Psychopathology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs007","article-title":"Basic self-disturbance predicts psychosis onset in the ultra high risk for psychosis \u201cprodromal\u201d population","volume":"38","author":"Nelson","year":"2012","journal-title":"Schizophr Bull"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000040","article-title":"Disordered self in the schizophrenia spectrum: a clinical and research perspective","volume":"22","author":"Parnas","year":"2014","journal-title":"Harvard Rev Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7893.2012.00381.x","article-title":"Not all first-episode psychosis is the same: preliminary evidence of greater basic self-disturbance in schizophrenia spectrum cases","volume":"7","author":"Nelson","year":"2013","journal-title":"Early intervention Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1600-0447.1999.tb10916.x","article-title":"Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration","volume":"100","author":"Mathew","year":"1999","journal-title":"Acta psychiatrica Scandinavica"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.744487","article-title":"Past and future explanations for depersonalization and derealization disorder: A role for predictive coding","volume":"16","author":"Gatus","year":"2022","journal-title":"Front Hum Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291716002051","article-title":"Salience attribution and its relationship to cannabis-induced psychotic symptoms","volume":"46","author":"Bloomfield","year":"2016","journal-title":"psychol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-23-09506.2001","article-title":"Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission","volume":"21","author":"Katona","year":"2001","journal-title":"J Neurosci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-009-0024-2","article-title":"Cannabis and psychosis\/schizophrenia: human studies","volume":"259","author":"D\u2019Souza","year":"2009","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2011.05.010","article-title":"Dissociative symptoms in patients with schizophrenia: relationships with childhood trauma and psychotic symptoms","volume":"53","author":"Sch\u00e4fer","year":"2012","journal-title":"Compr Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2015.09.024","article-title":"Phenomenology and neurobiology of self disorder in schizophrenia: Primary factors","volume":"169","author":"Borda","year":"2015","journal-title":"Schizophr Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40429-019-0235-1","article-title":"Ferraro, L. et\u00a0al. The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review","volume":"6","author":"Sideli","year":"2019","journal-title":"Curr Addict Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/add.14525","article-title":"Increasing potency and price of cannabis in Europe 2006-16","volume":"114","author":"Freeman","year":"2019","journal-title":"Addict (Abingdon England)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades, (1995-2014): analysis of current data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106431","article-title":"Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literature","volume":"179","author":"Mosca","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20514","article-title":"Beyond the \u201cat risk mental state\u201d concept: transitioning to transdiagnostic psychiatry","volume":"17","author":"McGorry","year":"2018","journal-title":"World Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106384","article-title":"Novel psychoactive substances and psychosis: A comprehensive systematic review of epidemiology, clinical features, neurobiology, and treatment","volume":"178","author":"Ricci","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076230","article-title":"Synthetic cathinones and neurotoxicity risks: A systematic review","volume":"24","author":"Daziani","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Res ed.)"},{"key":"B31","volume-title":"The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109118\u00f9","article-title":"Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study","volume":"229","author":"Ricci","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1343884","article-title":"Aberrant salience in cannabis-induced psychosis: a comparative study","volume":"14","author":"Ricci","year":"2024","journal-title":"Front Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720000082","article-title":"Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study","volume":"51","author":"Quattrone","year":"2021","journal-title":"psychol Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1159\/000325173","article-title":"Examination of anomalous self-experience in first-episode psychosis: interrater reliability","volume":"44","author":"M\u00f8ller","year":"2011","journal-title":"Psychopathology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.01.026","article-title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction","volume":"57","author":"Caspi","year":"2005","journal-title":"Biol Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbv032","article-title":"Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis","volume":"41","author":"Colizzi","year":"2015","journal-title":"Schizophr Bull"},{"key":"B38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41537-020-00110-7\u00f9","article-title":"Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis","volume":"6","author":"Dickens","year":"2020","journal-title":"NPJ Schizophr"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.05.027","article-title":"Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms","volume":"75","author":"Bloomfield","year":"2014","journal-title":"Biol Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2002.1o079.x","article-title":"Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia","volume":"105","author":"N\u00fa\u00f1ez","year":"2002","journal-title":"Acta psychiatrica Scandinavica"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2011.07.005","article-title":"The association between anomalous self-experience and suicidality in first-episode schizophrenia seems mediated by depression","volume":"53","author":"Haug","year":"2012","journal-title":"Compr Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2013.11.010","article-title":"Anomalous self-experiences contribute independently to social dysfunction in the early phases of schizophrenia and psychotic bipolar disorder","volume":"55","author":"Haug","year":"2014","journal-title":"Compr Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.165","article-title":"Peripheral endocannabinoid system dysregulation in first-episode psychosis","volume":"38","author":"Bioque","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2013.04.052","article-title":"Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia","volume":"79","author":"Ceccarini","year":"2013","journal-title":"NeuroImage"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.07.029","article-title":"Understanding marijuana\u2019s effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation","volume":"194","author":"Whitfield-Gabrieli","year":"2018","journal-title":"Schizophr Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e009888","DOI":"10.1136\/bmjopen-2015-009888","article-title":"Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study","volume":"6","author":"Patel","year":"2016","journal-title":"BMJ Open"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.concog.2013.01.009","article-title":"Anomalous self-experience in depersonalization and schizophrenia: a comparative investigation","volume":"22","author":"Sass","year":"2013","journal-title":"Consciousness Cogn"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clinical Res ed.)"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1733254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:32:01Z","timestamp":1767591121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1733254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":48,"alternative-id":["10.3389\/fpsyt.2025.1733254"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1733254","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"1733254"}}